180 Life Sciences Corp.
Q1 2024 13F Holders
Symbol
ETHZ
CUSIP
68236V302
Type
Equity
Class
COM
Num filings
8
Total reported value, excl. options
$52.6 k
Compare 2024 Q1 to
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
2024 Q2
Manager
Report Date
Value ($000)
Shares
Option Type